SEC Form 4 · accession 0001209191-17-058490
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis W Coleman
Director
Period of report
Oct 27, 2017
Accepted (ET)
Oct 31, 2017 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 27, 2017 | P | 65,000 | $4.0731 | A | 125,000 | I | By Trust |
| Common Stock | holding | — | — | — | 3,000 | I | By Wife's IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.00 to $4.10 on October 27, 2017. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
- F2On September 20, 2016, the reporting person filed a Form 4 which inadvertently reported that the acquisition of 50,000 shares of the Issuer's Common Stock was held directly by the reporting person. Subsequently, on December 22, 2016, the reporting person disposed of 10,000 shares. This Form 4 corrects the reporting person's holdings to reflect that the remaining 40,000 shares are held indirectly by the reporting person's trust.